Your browser doesn't support javascript.
loading
Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes.
Hsiao, Chen-Yuan; Chen, Tien-Hua; Huang, Ben-Shian; Chen, Po-Han; Su, Cheng-Hsi; Shyu, Jia-Fwu; Tsai, Pei-Jiun.
Affiliation
  • Hsiao CY; Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan.
  • Chen TH; Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei 112, Taiwan.
  • Huang BS; Department of Obstetrics and Gynecology, Veterans General Hospital, Taipei 112, Taiwan.
  • Chen PH; Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei 112, Taiwan.
  • Su CH; Department of Surgery, Cheng Hsin General Hospital, Taipei 112, Taiwan.
  • Shyu JF; Department of Biology and Anatomy, National Defense Medical Center, Taipei 114, Taiwan.
  • Tsai PJ; Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei 112, Taiwan.
World J Stem Cells ; 12(2): 139-151, 2020 Feb 26.
Article de En | MEDLINE | ID: mdl-32184938
ABSTRACT

BACKGROUND:

Despite the availability of current therapies, including oral antidiabetic drugs and insulin, for controlling the symptoms caused by high blood glucose, it is difficult to cure diabetes mellitus, especially type 1 diabetes mellitus.

AIM:

Cell therapies using mesenchymal stem cells (MSCs) may be a promising option. However, the therapeutic mechanisms by which MSCs exert their effects, such as whether they can differentiate into insulin-producing cells (IPCs) before transplantation, are uncertain.

METHODS:

In this study, we used three types of differentiation media over 10 d to generate IPCs from human Wharton's jelly MSCs (hWJ-MSCs). We further transplanted the undifferentiated hWJ-MSCs and differentiated IPCs derived from them into the portal vein of rats with streptozotocin-induced diabetes, and recorded the physiological and pathological changes.

RESULTS:

Using fluorescent staining and C-peptide enzyme-linked immunoassay, we were able to successfully induce the differentiation of hWJ-MSCs into IPCs. Transplantation of both IPCs derived from hWJ-MSCs and undifferentiated hWJ-MSCs had the therapeutic effect of ameliorating blood glucose levels and improving intraperitoneal glucose tolerance tests. The transplanted IPCs homed to the pancreas and functionally survived for at least 8 wk after transplantation, whereas the undifferentiated hWJ-MSCs were able to improve the insulitis and ameliorate the serum inflammatory cytokine in streptozotocin-induced diabetic rats.

CONCLUSION:

Differentiated IPCs can significantly improve blood glucose levels in diabetic rats due to the continuous secretion of insulin by transplanted cells that survive in the islets of diabetic rats. Transplantation of undifferentiated hWJ-MSCs can significantly improve insulitis and re-balance the inflammatory condition in diabetic rats with only a slight improvement in blood glucose levels.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: World J Stem Cells Année: 2020 Type de document: Article Pays d'affiliation: Taïwan

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: World J Stem Cells Année: 2020 Type de document: Article Pays d'affiliation: Taïwan